Generation of reactive oxygen species by human mesothelioma cells by Kahlos, K et al.
Tumour cell lines generate reactive oxygen species (ROS) super-
oxide and hydrogen peroxide (H2O2), and this generation, if also
occurring in vivo, might have effects on tumour proliferation and
drug resistance (Szatrowski and Nathan, 1991; Burdon, 1995).
ROS production has also been suggested to have an important role
in mitochondrial control of cell survival and apoptosis (Burdon,
1997; Kroemer et al, 1997). Manganese superoxide dismutase
(MnSOD), a mitochondrial antioxidant enzyme, dismutates super-
oxide to hydrogen peroxide and oxygen (Fridovich, 1975) and is
induced by several cytokines (Wong and Goeddel, 1988; Hirose
et al, 1993), changes in the cellular redox state (Warner et al, 1996)
and asbestos fibres (Janssen et al, 1992). MnSOD eliminates mito-
chondrial superoxide radicals and may also contribute to the cell
survival of non-malignant and malignant cells. In fact, it has been
reported recently that MnSOD may be anti-apoptotic (Slater et al,
1995; Keller et al, 1998; Manna et al, 1998).
Human pleural mesothelioma, which originates from mesothe-
lial cells, is a fatal tumour associated with occupational exposure
to asbestos fibres. Its pathogenesis has been postulated to be
associated with the generation of free radicals (Kamp et al, 1992;
Mossman et al, 1996). In contrast to previous observations, which
have shown that MnSOD is usually low in malignant tumours
(Oberley and Buettner, 1979; Oberley and Oberley, 1997), we
have recently shown that the mRNA level, immunoreactive
protein and specific activity of MnSOD are highly expressed in the
tumour cells of malignant mesotheliomas when compared to
healthy pleura or non-malignant transformed human mesothelial
cells (Met5A) (Kinnula et al, 1996; Kahlos et al, 1998).
Mesothelioma is resistant to cytotoxic drugs and radiation, both
of which are known to induce generation of ROS (Sinha and
Mimnaugh, 1990; Nakano et al, 1996). Accordingly, mesothe-
lioma cell line cells are very resistant to a superoxide radical-
producing oxidant, menadione, and to epirubicin, which is an
anthracycline often used in the treatment of mesothelioma
(Kinnula et al, 1996; Kahlos et al, 1998).
We hypothesize that the increase of MnSOD in mesothelioma
cells may affect ROS levels in the mitochondria or cytosolic
compartments of these cells. To verify that high MnSOD in
mesothelioma cells is related to an increased level of this enzyme in
the mitochondrial compartment, and not to an increased number or
volume of mitochondria per cell, the activities of two constitutive
mitochondrial enzymes, citrate synthase and cytochrome
c oxidase, were measured. In order to test the hypothesis that super-
oxide levels in these cells with different MnSOD activities may be
altered, superoxide production was assayed in isolated mitochon-
dria of malignant mesothelioma cell line cells (M38K, high
MnSOD level) and of non-malignant mesothelial cell line cells
(Met5A, low MnSOD level). Then, in order to investigate whether
the altered level of superoxide at the mitochondria would lead to an
increase in H2O2 formation and to increased oxidant stress in these
cells, peroxide formation by these cells was estimated with a fluori-
metric assay using 2¢,7¢ -dichlorodihydrofluorescein as a probe. To
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nant cells, additional experiments were conducted in cells pre-
treated either with aminotriazole (ATZ) to inhibit catalase or
buthionine sulfoximine (BSO) to deplete glutathione by inhibiting
the rate-limiting enzyme in glutathione synthesis, g-glutamylcys-
teine synthetase (g-GCS). These pre-treated cells were exposed to
menadione, which is a quinone known to generate free radicals
intracellularly (Powis, 1989).
METHODS
Cell culture
Continuous mesothelioma cell line cells (M38K) along with five
other mesothelioma cell lines were originally established and char-
acterized from tumours of untreated mesothelioma patients (Pelin-
Enlund et al, 1990). M38K cells were chosen because they contain
the highest MnSOD activity of these cell lines and are extremely
resistant to oxidant-induced cytotoxicity (Kinnula et al, 1996,
1998; Kahlos et al, 1998). Transformed human pleural mesothelial
cells (Met5A) were SV-40 virus transformed, immortalized, non-
tumorigenic and near-diploid cells (Ke et al, 1989), and were a gift
from the National Cancer Institute, Bethesda, MD, USA (Dr CC
Harris). Both cell types were cultured on uncoated plastic T25
flasks (Nunclon, Nalge Nunc International, Denmark) or on
24-well microtiter plates (Falcon Multiwell 3047, Becton
Dickinson Labware, NJ, USA) in RPMI-1640 medium supple-
mented with heat-inactivated 10% fetal calf serum, 0.03%
L-glutamine, and the antibiotics streptomycin and penicillin (all
from LTI Life Technologies, Paisley, UK) at 37°C in 5% carbon
dioxide atmosphere.
Enzyme activities
All enzyme activities were measured by spectrophotometric
methods from cells disrupted with 1% Triton X-100. Total super-
oxide dismutase activity was measured according to the method of
Crapo et al (1978). The activity was assessed following the
decrease in the rate of reduction (the rate of change in absorbancy
at 550 nm) of 12.8 mM cytochrome c (Sigma, St Louis, MO, USA)
in the presence of 0.5 mM xanthine (Sigma) and xanthine oxidase
(Boehringer Mannheim, Germany). MnSOD activity was distin-
guished from copper–zinc superoxide dismutase (CuZnSOD)
activity by its resistance to 1 mM potassium cyanide (Riedel-de-
Haen, Seetze, Germany). The activity of citrate synthase, a marker
enzyme for the mitochondrial matrix, was assessed according to
the method of Shepherd and Garland (1969). The cell sample
was added to the reaction solution containing 10 mML -malate,
41 mg ml–1 malate dehydrogenase and 0.5 mM nicotinamide–
adenine dinucleotide (NAD) (Sigma), and the reaction was
initiated with 0.1 mM acetyl–CoA (coenzyme A). Citrate synthase
activity was measured by following the rate of reduction of NAD
(Shepherd and Garland, 1969). As a marker enzyme for the mito-
chondrial inner membrane cytochrome c oxidase activity was
assayed by the method of Wharton and Tzagoloff (1969). The rate
of oxidation of 30 mM reduced cytochrome c in 50 mM potassium
phosphate buffer was measured by following the decrease in the
absorbancy of its a band at 550 nm (Wharton and Tzagoloff,
1969). The protein concentration was measured according to the
method of Lowry and co-workers (1951).
Generation of superoxide by isolated mitochondria
A chemiluminescent probe, lucigenin, was employed to measure
superoxide production by isolated mitochondria with a lumi-
nometer (1253 Luminometer, Bio-Orbit, Finland). The mito-
chondria were isolated as described by Pitkänen et al (1996).
Frozen-thawed mitochondria (15 mg of mitochondrial protein) was
added to a solution of 10 mM K2HPO4, pH 10.5, and the cuvette
was placed into the counter. Background was subtracted and
counting was initiated by adding the reduced form of NAD
(NADH) (Sigma, 50 mg in 10 ml water) (Liochev and Fridovich,
1997) as a substrate for the respiratory chain electron transport.
The luminometer indicates the rates of superoxide production as
counts per second measured after 30 s when the steady state has
been reached. These units were converted to nmol min–1 mg–1 of
mitochondrial protein using a standard curve described by
Pitkänen and Robinson (1996).
Oxidant production by intact cells
Generation of H2O2 and other peroxides was measured using a
fluorimetric microplate assay established by Rosenkranz et al
(1992). A fluorescent probe, 2¢,7¢-dichlorodihydrofluorescein-
diacetate (DCDHF-DA) (Molecular Probes, OR, USA), diffuses to
the cell, hydrolyses to 2¢,7¢-dichlorodihydrofluorescein and is
oxidized to the highly fluorescent compound 2¢,7¢ -dichlorofluo-
rescein in the presence of intracellular H2O2 and hydroperoxides
(Bass et al, 1983; Cathcart et al, 1983). The cells, cultured on
24-well microtiter plates (80 000 cells per well) to near-conflu-
ency (2–3 days), were incubated for 30 min with 5 mM DCDHF-
DA. The cultures were then washed with phosphate-buffered
saline (PBS), and the intensity of fluorescence was measured by a
spectrofluorimeter (excitation wavelength 485 nm, emission
wavelength 535 nm) capable of reading microtiter plates (1420
Victor multilabel counter, Wallac, Inc., Turku, Finland). The
fluoresence intensity was followed every 10 min for 120 min, and
each experiment was done in quadruplicate at the time. The
background (the fluorescence of cells without DCDHF-DA pre-
labelling) was subtracted from the results. A similar initial amount
of cells was co-cultured in equal conditions for each experiment,
and at the time of the fluorimetric analysis the cell protein content
was assessed from these co-cultured plates according to the
Bio-Rad method (Bio-Rad, Hercules, CA, USA) (Bradford, 1976).
The final results are expressed as fluorescence intensity per cell
protein (means of three independent experiments ± s.d.).
Pre-treatment with aminotriazole or buthionine
sulfoximine
The cells were pre-treated either with ATZ (Sigma, 30 mM for
60 min) to inactivate catalase, or with BSO (Sigma, 0.2 mM for
15 h) to inhibit g-GCS in order to cause glutathione depletion. The
concentrations and effects of these inhibitors have been reported in
earlier investigations (Margoliash et al, 1960; Buckley et al, 1991;
Kinnula et al, 1992a, 1998). These concentrations are not toxic,
and they have caused at least 85% inhibition of catalase and deple-
tion of glutathione in these same cells (Kinnula et al, 1992a). After
the pre-treatments the cells were washed and incubated with 5 mM
DCDHF-DA for 30 min, washed and measured for fluorescence.
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Washed cells prelabelled with DCDHF-DA were exposed to a
superoxide producing oxidant, menadione (10 mM in PBS), and
measured immediately for fluorescence. This concentration was
chosen because our previous studies have shown it to be margin-
ally toxic to these cells in these incubation conditions in vitro
(Kahlos et al, 1998).
Statistical analysis
The results are expressed as mean ± s.d. of three to seven
experiments. Two groups were compared using a two-tailed
Student’s  t-test and multiple groups were compared using analysis
of variance and Scheffe’s post hoc test. P < 0.05 was considered
significant.
RESULTS
MnSOD, citrate synthase and cytochrome c oxidase
Previous studies on alveolar type II cells of hyperoxic rats and
human renal carcinoma cells of granular type have shown that the
elevated level of MnSOD in these cells is at least partly explained
by increased volume of mitochondria per cell (Oberley et al, 1994;
Vincent et al, 1994). The results of the present study confirm our
earlier finding on elevated MnSOD activity in M38K cells as
compared to Met5A cells (Kinnula et al, 1996), the specific
activity of MnSOD being 36.0 ± 3.4 U mg–1 protein in M38K cells
and 1.8 ± 1.0 U mg–1 protein in Met5A cells. Moreover, the activi-
ties of the mitochondrial enzymes citrate synthase and cytochrome
c oxidase, which have been used as constitutive mitochondrial
enzymes (Freeman et al, 1986; Oberley et al, 1987; Vuorinen et al,
1995), did not differ significantly between the two cell lines. The
activity of citrate synthase was 45.9 ± 5.3 nmol min–1 mg–1 protein
in M38K cells and 32.7 ± 10.7 nmol min–1 mg–1 protein in Met5A
cells (P = 0.127), the corresponding activities for cytochrome
c oxidase being 3.2 ± 1.0 and 2.4 ± 0.9 nmol min–1 mg–1 protein
(P = 0.340). The ratios of MnSOD to these enzymes in these two
cell lines are presented in Figure 1, and they show the increase of
MnSOD activity to be due to the elevated level of the enzyme per
mitochondria.
Mitochondrial superoxide production
Superoxide generation in the mitochondrial compartment of
M38K mesothelioma cells and Met5A mesothelial cells was
assessed by lucigenin chemiluminescence. Very small amounts of
superoxide were generated before respiratory chain was initiated
(i.e. background which was subtracted). Isolated mitochondria of
M38K cells generated significantly less superoxide than Met5A
cells (0.1 ± 0.01 vs 0.37 ± 0.03 counts per s for every 15 mg of
mitochondrial protein respectively; P = 0.00007). Figure 2 shows
mitochondrial superoxide generation standardized with xanthine
oxidase (Pitkänen and Robinson, 1996).
Oxidant production by intact cells
To further assess ROS generation in these cells, DCDHF-DA
fluorescence was used to follow oxidant generation in intact cells
and in cells that had been pre-treated with ATZ or BSO to inhibit
catalase or to cause glutathione depletion respectively. When
Reactive oxygen species generation in human mesothelioma cells 27
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Figure 1 The ratio of MnSOD activity to the activities of citrate synthase (A)
and cytochrome c oxidase (B) in non-malignant mesothelial Met5A cells and
mesothelioma M38K cells.* P < 0.05 compared to Met5A cells (n = 3)
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Figure 2 Superoxide production in isolated mitochondria of Met5A
mesothelial cells and M38K mesothelioma cells.* P < 0.05 compared to
Met5A cells (n = 3)standardized against the cell protein, the fluorescence intensity
did not differ significantly between M38K and Met5A cells
(Figure 3A). In particular, catalase inhibition caused a potent
increase in the fluorescence of M38K cells and Met5A cells, the
enhancement being 213% in M38K cells and 244% in Met5A
cells. On the other hand, glutathione depletion did not cause a
significant change in the fluorescence of these cells (Figure 3B).
Additional experiments were conducted to assess the effects
of exogenous oxidant on the ROS generation of these cells.
Menadione (10 mM) caused 68% and 59% increases in the fluores-
cence in M38K and Met5A cells, respectively, and this response
was parallel in the two cell types. The fluorescence in menadione-
exposed cells was markedly enhanced by ATZ pre-treatment in
both cell types, while the enhancement by BSO pre-treatment was
less intense and only significant in M38K cells (Figure 4).
DISCUSSION
Although many studies have shown that MnSOD is lower in
malignant tissue and malignant cells than in their non-malignant
counterparts (Sun, 1990), MnSOD has been shown to be high in
human thyroid tumours (Nishida et al, 1993), human renal adeno-
carcinoma of granular cell type (Oberley et al, 1994), human brain
tumours (Cobbs et al, 1996) and human malignant mesothelioma
(Kahlos et al, 1998) as compared to corresponding non-malignant
control tissues. The mesothelioma tumour biopsies and cell lines
used in our studies are from untreated mesothelioma patients.
Mesothelioma is a tumour which arises from the malignant trans-
formation of mesothelial cells. Met5A cells, though not primary
mesothelial cells, are considered representative in vitro models
for examining the biology of non-malignant mesothelial cells
(Ke et al, 1989).
MnSOD is coded by a nuclear gene and, therefore, is translated
in the extramitochondrial compartment. The translation product is
a precursor which contains a mitochondrial targeting sequence so
that practically all enzyme is found in the mitochondrion
(Shimoda-Matsubayashi et al, 1996). The elevation of MnSOD in
cells may be associated either with an increased level of this
enzyme in the mitochondria or with an increased number of mito-
chondria per cell. In fact, an elevated expression of MnSOD in
human renal carcinoma of granular cell type (Oberley et al, 1994)
and in alveolar type II cells of hyperoxic rats (Vincent et al, 1994)
was associated not only with increased MnSOD expression per
mitochondrion, but also with an increased number or volume of
mitochondria per cell. Cytochrome c oxidase, a mitochondrial
inner membrane enzyme, is known to be stable, and it has been
used as a mitochondrial marker enzyme (Vuorinen et al, 1995),
whereas citrate synthase is a marker for the mitochondrial matrix.
When compared to the activities of these enzymes, MnSOD
activity was sixfold higher in mesothelioma M38K cells compared
to Met5A cells, reflecting markedly enhanced MnSOD activity per
mitochondrion.
Although lucigenin chemiluminescence is not specific to super-
oxide alone, the use of lucigenin permits a rough estimation of the
28 K Kahlos et al
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Figure 3 (A) Oxidant production by intact mesothelioma M38K cells (s) and
mesothelial Met5A cells (O) using DCDHF-DA as a fluorescent probe. The results
are expressed as fluorescence units per mg of protein per well at different time
points during the first 120 min incubation (mean ± s.d. of three individual
experiments done in quadruplicate). (B) The effect of catalase inhibition by
aminotriazole (ATZ) pre-treatment and GSH depletion by buthionine sulfoximine
(BSO) pre-treatment on H2O2 generation by Met5A and M38K cells. The results are
presented as the percentage of the fluorescence of untreated control cells.
* P < 0.05 compared to control cells (n = 3). No significant differences were found
between the two cell types
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Figure 4 The relative DCDHF-mediated fluorescence of Met5A cells and
M38K cells exposed to menadione (10 mM) with pre-treatments with either
aminotriazole or buthionine sulfoximine (menad. = menadione exposure
without pre-treatment; menad.ATZ = menadione exposure on cells pre-
treated with aminotriazole; menad. BSO = menadione exposure on cells pre-
treated with buthionine sulfoximine). The results are presented as the
percentage of the fluorescence of unexposed and untreated control cells
(means of three to seven experiments each done in quadruplicate ± s.d.).
* P < 0.05 compared to unexposed control cells, # P < 0.05 compared to
menadione-exposed cellsrate of superoxide production (Pitkänen and Robinson, 1996). The
method does not measure total superoxide generation but its net
appearance which is the difference between its total production
and scavenging. This study showed that the mitochondrial super-
oxide levels of malignant M38K cells with their higher MnSOD
activity per mitochondrion were 72% less than that of non-
malignant Met5A cells. Thus, the observed level of superoxide in
mitochondrial preparations seemed to be highly dependent on the
level of active MnSOD. Such a correlation between mitochondrial
superoxide level and MnSOD has been previously shown in
cultured human fibroblasts (Pitkänen and Robinson, 1996). In one
previous study, the mitochondria of rat hepatoma cells were shown
to have low MnSOD activity, which was associated with normal
mitochondrial superoxide generation (Bize et al, 1980). No studies
are available on mitochondrial superoxide production in tumours
expressing high mitochondrial MnSOD.
Mitochondrial free radical generation may have a significant
effect on the cellular redox state, cell proliferation and apoptosis,
which are important features in cancer biology (Slater et al, 1995;
Burdon, 1997). ROS and changes in the redox state of the cell can
initiate reactions leading to the disruption of mitochondrial
membrane, depletion of high-energy nucleotides, disturbance of
calcium homeostasis and activation of genes, which may result in
cell death (Kroemer, 1997). In fact, our recent study showed that
M38K cells are much more resistant than Met5A cells in main-
taining their cellular energy state, ATP level and cell survival
(Kahlos et al, 1998).
Although MnSOD dismutates superoxide to oxygen and H2O2,
which is freely diffusible, increased superoxide elimination in the
mitochondria did not lead to increased H2O2 production in intact
mesothelioma cells. One explanation could be that these mesothe-
lioma cells express higher levels of H2O2-scavenging enzymes and
glutathione (Kahlos et al, 1998; Kinnula et al, 1998). On the other
hand, the generation of ROS in intact cells is not necessarily
parallel with the free radical generation of the mitochondria. ROS
can also be scavenged by mitochondrial H2O2-scavenging mecha-
nisms (Radi et al, 1991). They are also generated and scavenged in
other parts of the cell. DCDHF-DA, which was used for the detec-
tion of ROS in intact cells, diffuses across the cell membrane and
incorporates into the hydrophobic lipid regions in the cell (Bass
et al, 1983). Although this method is widely used to measure
H2O2 production, it detects also various peroxides (Royall and
Ischiropoulos, 1993). Since the probe can theoretically move from
one area to another both inside and outside the cell, its localization
does not indicate the precise compartment, where the original
reaction has occurred. In spite of the fact that DCDHF-DA has
been shown to detect intracellular ROS generation, the assay
system can also detect fluorescent probe leaked through the cell
membrane or ROS generated on the plasma membrane (Royall and
Ischiropoulos, 1993). In our system, the assay was calibrated to
measure the fluorescence on the bottom of each well, because our
cells are adherent. Furthermore, the volume of the assay medium
was kept as small as possible to minimize the effects caused by
dilution. Based on these assumptions, we can conclude that the net
generation of H2O2 and other peroxides was very similar in malig-
nant M38K cells and non-malignant Met5A cells.
Antioxidants, such as superoxide dismutases, may be anti-apop-
totic (Troy and Shelanski, 1994; Keller et al, 1998; Manna et al,
1998). The role of MnSOD in this issue is, however, complicated
because there is powerful evidence to suggest that MnSOD is
antiproliferative in malignant cells (Oberley and Oberley, 1997). It
has been shown that transfection of the MnSOD gene leads to a
suppression of the malignant phenotype and decreased cell prolif-
eration. The situation is more complicated in vivo, where simulta-
neous induction of multiple antioxidant enzymes is possible
(Tew, 1994; Kahlos et al, 1998; Kinnula et al, 1998). The same is
true of M38K cells, which represent an immortal cell line estab-
lished from one of our mesothelioma patients. In fact, M38K
mesothelioma cells are not only high in MnSOD, but also have
higher catalase, glutathione-S-transferase and glutathione contents
than Met5A mesothelial cells (Kahlos et al, 1998; Kinnula et al,
1998).
The relative role of various antioxidants in scavenging H2O2
may vary considerably in different cell types. Previous studies
have indicated that catalase activity is high in alveolar pneumo-
cytes and macrophages, and catalase inhibition significantly
reduces H2O2 consumption by these cells (Kinnula et al, 1992b;
Pietarinen et al, 1995). On the other hand, endothelial cells appear
to protect themselves by the glutathione redox cycle, but not by
catalase (Schraufstätter et al, 1985; Andreoli et al, 1992; Kinnula
et al, 1992c). To further examine which antioxidant enzyme
mechanism plays a major role as a free radical scavenger in these
cells, we inhibited catalase with ATZ or g-GCS with BSO and
measured oxidant generation in both intact unexposed cells and
cells exposed to menadione. Both unexposed and exposed cells
generated significantly more H2O2 if catalase had been inhibited
than the cells in which g-GCS had been inhibited. This effect was
similar in non-malignant mesothelial and malignant mesothelioma
cells, which also suggests that other undefined mechanisms
contribute to the oxidant generation in these cells.
In conclusion, human mesothelioma cells contain highly
elevated MnSOD levels and simultaneously decreased generation
of superoxide in the mitochondrial compartment of these cells.
This phenomenon, if also occurring in vivo, may prolong cell
survival and contribute to the oxidant resistance of these cells. The
production of H2O2 or other peroxides by intact mesothelioma
cells did not differ between non-malignant mesothelial cells and
malignant mesothelioma cells, possibly due to the previously
observed effective H2O2-scavenging capacity of these mesothe-
lioma cells. The effects of the lowered free radical generation on
the cell survival and drug resistance of these cells remains to be
investigated.
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